Medpace, IQVIA upgraded at Barclays; says AI concerns are overdone
Source: SeekingAlpha
2026-03-06 13:44:14 ET
More on IQVIA, Medpace
- IQVIA Holdings: Still Exceeding Expectations As A Stealth Compounder
- IQVIA Holdings Inc. (IQV) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
- Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call Transcript
- Charles River announces divestitures, updates guidance
- Medpace outlines 2026 revenue growth of up to 12.8% amid backlog normalization and metabolic trial shifts
Read the full article on Seeking Alpha
For further details see:
Medpace, IQVIA upgraded at Barclays; says AI concerns are overdone
IQVIA Holdings Inc.
NASDAQ: IQV
IQV Trading
-3.02% G/L:
$173.66 Last:
601,815 Volume:
$178.12 Open:
IQV Latest News
IQV Stock Data
$31,275,595,000
168,494,820
N/A
548
N/A
Biotechnology & Life Sciences
Healthcare
US
Durham
